Oncimmune Holdings plc (LON: ONC), a Leading Global Immunodiagnostics Group, will be keynoting the China BioMed Innovation and Investment Conference (CBIIC) on Sunday 22nd September 2019, at 9:00 am CST (2:00 am BST) in Suzhou, China.
The Company’s presentation will be made available under the IR section on Oncimmune’s website on Monday 23rd September 2019.
Adam Hill, Chief Executive Officer of Oncimmune, will be presenting an overview of the company, including progress in delivering the forward strategy. He will be available to take questions following the event.
Oncimmune Holdings, headquartered at its laboratory facility in Nottingham, UK, has a discovery research centre in Dortmund, Germany and a CLIA lab in Kansas, US as well as an office in London, UK and a partner representative office in Shanghai, China. Oncimmune joined the Alternative Investment Market (AIM) of the London Stock Exchange in May 2016 under the ticker LON: ONC
